Sanofi S.A. (SAN)
SIX
Closed
Oct 6, 2026
Day's Range
66.8552 wk Range
66.85Overview - SAN - Sanofi S.A.
Key Statistics
Valuation
Enterprise Value
97.83B
P/E (Trailing)
‪23.61‬
Price / Book
‪1.31‬
EV / EBITDA
‪7.65‬
Profitability
Gross Margin
‪75.47%‬
Profit Margin
‪8.09%‬
Operating Margin
‪21.03%‬
Return on Assets
‪5.09%‬
Return on Equity
‪5.70%‬
Ownership
Shares Outstanding
1.21B
Float
1.08B
Held by Insiders
‪10.31%‬
Held by Institutions
‪43.46%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪72.39‬
200-Day Avg
‪72.83‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Peers - SAN - Sanofi S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- SANSIXSanofi S.A.-1.95%52-week change23.62P/E (Trailing)‪8.09%‬Profit Margin
- LLYSIXEli Lilly and Company+40.21%52-week change39.22P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson+22.72%52-week change31.23P/E (Trailing)‪21.48%‬Profit Margin
- MRKSIXMerck & Co., Inc.+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- ROPSIXRoche Holding AG+17.79%52-week change22.57P/E (Trailing)‪19.60%‬Profit Margin
- NOVNEESIXNovartis AG+17.54%52-week change21.32P/E (Trailing)‪22.50%‬Profit Margin
- BAYNSIXBayer AG+21.56%52-week change8.39P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - SAN - Sanofi S.A.
About
Sanofi S.A. is a French biopharmaceutical company headquartered in Paris. Sanofi focuses on the research, development, manufacturing, and commercialization of medicines and vaccines for patients worldwide. Its current business is organized around specialty care, vaccines, and general medicines, with products spanning…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
